Harris SL, LaRue R, Weiss MJ (in press), Programmatic issues. In: Autism Spectrum Disorders: Applied Behavior Analysis, Evidence and Practice, Sturmey P, Fitzer A, eds. Austin, Texas: PRO-ED.
Heflin LJ, Simpson RL (1998), Interventions for children and youth with autism: prudent choices in a world of exaggerated claims and empty promises. Part I: intervention and treatment option review. Focus on Autism and Other Developmental Disabilities 13:194-211.
Hollander E, Phillips A, Chaplin W et al. (2005), A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30(3):582-589.
Kahng S, Abt KA, Schonbachler HE (2001), Assessment and treatment of low-rate high-intensity problem behavior. J Appl Behav Anal 34(2):225-228.
Lovaas OI (1987), Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 55(1):3-9 [see comment].
McClannahan LE, Krantz PJ (2004), Some guidelines for selecting behavioral intervention programs for children with autism. In: Using Evidence in Social Work Practice: Behavioral Perspectives, Briggs HE, Rzepnicki TL, eds. Chicago: Lyceum Books.
McCracken JT, McGough J, Shah B et al. (2002), Risperidone in children with autism and serious behavioral problems. N Engl J Med 347(5):314-321 [see comments].
McDougle CJ, Holmes JP, Carlson DC et al. (1998), A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry 55(7):633-641 [see comment].
